A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema (HAE)

  • van Doorn, M. B. A.
  • Nuijens, J.
  • van Dam, T.
  • Levi, M.
  • Hack, E.
  • Cohen, A. F.
  • Burggraaf, J.

  • 1Pharming, Archimedesweg 4, 2333 CN Leiden, The Netherlands

    2Centre for Human Drug Research, Leiden

    3Academic Medical Centre, Amsterdam; Central Laboratory Blood Transfusion Service, Amsterdam

British Journal of Clinical Pharmacology 59(1):p 136, January 2005.
Copyright © 2005 Blackwell Publishing Ltd.
View full text|Download PDF